Contrast-echocardiography: confirmation of patency of laser channels after transmyocardial laser revascularization

O Reuthebuch1, K Berwing, M Roth

  • 1Department of Cardio-Vascular Surgery, Unispital Zürich, Zürich, Switzerland. oliver.reuthebuch@chi.usz.ch

Insights

This study provides the first clinical evidence of long-term patency for transmyocardial laser revascularization channels in humans. Echocardiography confirmed perfusion of myocardial channels in 67% of patients, demonstrating long-term channel viability.

Area of Science:

  • Cardiovascular Surgery
  • Medical Imaging
  • Regenerative Medicine

Background:

  • Long-term evidence for channel perfusion after transmyocardial laser revascularization (TMLR) in humans is lacking, with current data primarily from autopsy findings.
  • TMLR aims to improve myocardial perfusion by creating channels through the left ventricular wall.

Purpose of the Study:

  • To provide the first clinical evidence of long-term channel patency following TMLR in human subjects.
  • To assess the perfusion and viability of laser-created channels in the myocardium.

Main Methods:

  • Fifteen patients undergoing TMLR were investigated using echocardiography.
  • Contrast medium was injected into the left ventricular cavity and the left main coronary artery to visualize channel perfusion.
  • In some patients, contrast was also injected into bypass grafts.

Main Results:

  • In 67% of patients (10 out of 15), one or two laser channels in the apical left ventricular myocardium were successfully visualized.
  • Channels demonstrated systolic perfusion, with myocardial opacification extending to a mean width of 1.4 cm, depth of 0.71 cm, and area of 1.0 cm².
  • Contrast medium washout occurred via the coronary venous system within an average of 9 systoles.

Conclusions:

  • This study presents the first clinical evidence of long-term patency of transmyocardial laser revascularization channels in humans.
  • The findings demonstrate that TMLR channels can remain patent and perfused long-term, allowing myocardial opacification via the left ventricular cavity.
Abstract

Related Concept Videos